Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × OTHER × Amifampridine × Clear all

Status

No longer available 3 Unknown 1 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Conditions

Myasthenic Syndromes, Congenital 1 Lambert-Eaton Myasthenic Syndrome 1

Interventions

gallium 68 PSMA-11 2 Magnetic Resonance Spectroscopy 2 motexafin gadolinium 1 glucarpidase 1 Positron-Emission Tomography 1 Oxaliplatin 1 Leucovorin 1 Laparoscopy 1 Gemtuzumab 1 Gadolinium 1 Fluorouracil 1 Carboxypeptidases 1 Amifampridine 1 3-Iodobenzylguanidine 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00872950 2022-04-11

LEMS

Lahey Clinic

Approved for marketing

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

Data powered by HemOnc (CC BY 4.0) Colophon ⚡